219 related articles for article (PubMed ID: 11023674)
1. Serum levels of ifn-inducible PROTEIN-10 relating to the activity of systemic lupus erythematosus.
Narumi S; Takeuchi T; Kobayashi Y; Konishi K
Cytokine; 2000 Oct; 12(10):1561-5. PubMed ID: 11023674
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis.
Fujii H; Shimada Y; Hasegawa M; Takehara K; Sato S
J Dermatol Sci; 2004 Jun; 35(1):43-51. PubMed ID: 15194146
[TBL] [Abstract][Full Text] [Related]
3. [Serum levels of several chemokines in patients with rheumatoid arthritis].
Wu HX; Zhang Y; Zhu YL
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):534-7. PubMed ID: 15949333
[TBL] [Abstract][Full Text] [Related]
4. A role for TARC/CCL17, a CC chemokine, in systemic lupus erythematosus.
Okamoto H; Koizumi K; Yamanaka H; Saito T; Kamatani N
J Rheumatol; 2003 Nov; 30(11):2369-73. PubMed ID: 14677179
[TBL] [Abstract][Full Text] [Related]
5. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
Liu ZC; Zhou QL; Li XZ; Yang JH; Ao X; Veeraragoo P; Zuo XX
Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of beta-chemokines in systemic lupus erythematosus.
Kaneko H; Ogasawara H; Naito T; Akimoto H; Lee S; Hishikawa T; Sekigawa I; Tokano Y; Takasaki Y; Hirose SI; Hashimoto H
J Rheumatol; 1999 Mar; 26(3):568-73. PubMed ID: 10090164
[TBL] [Abstract][Full Text] [Related]
7. [Expression of monocyte chemoattractant protein-1 and lupus nephritis].
Liu ZJ; Lin JY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):491-5. PubMed ID: 16178446
[TBL] [Abstract][Full Text] [Related]
8. Interaction between oxidative stress and chemokines: possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis.
Shah D; Wanchu A; Bhatnagar A
Immunobiology; 2011 Sep; 216(9):1010-7. PubMed ID: 21601309
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
10. Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis.
Härle P; Pongratz G; Weidler C; Büttner R; Schölmerich J; Straub RH
Ann Rheum Dis; 2004 Jul; 63(7):809-16. PubMed ID: 15194576
[TBL] [Abstract][Full Text] [Related]
11. Raised serum APRIL levels in patients with systemic lupus erythematosus.
Koyama T; Tsukamoto H; Miyagi Y; Himeji D; Otsuka J; Miyagawa H; Harada M; Horiuchi T
Ann Rheum Dis; 2005 Jul; 64(7):1065-7. PubMed ID: 15576416
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
Henneken M; Dörner T; Burmester GR; Berek C
Arthritis Res Ther; 2005; 7(5):R1001-13. PubMed ID: 16207316
[TBL] [Abstract][Full Text] [Related]
13. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus.
Lit LC; Wong CK; Tam LS; Li EK; Lam CW
Ann Rheum Dis; 2006 Feb; 65(2):209-15. PubMed ID: 15975968
[TBL] [Abstract][Full Text] [Related]
14. Raised serum level of APRIL in patients with systemic lupus erythematosus: correlations with disease activity indices.
Hegazy M; Darwish H; Darweesh H; El-Shehaby A; Emad Y
Clin Immunol; 2010 Apr; 135(1):118-24. PubMed ID: 20116334
[TBL] [Abstract][Full Text] [Related]
15. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
Hepburn AL; Mason JC; Davies KA
Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
[TBL] [Abstract][Full Text] [Related]
16. Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus.
Lub-de Hooge MN; de Vries EG; de Jong S; Bijl M
Ann Rheum Dis; 2005 Jun; 64(6):854-8. PubMed ID: 15564310
[TBL] [Abstract][Full Text] [Related]
17. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
Morgan PE; Sturgess AD; Davies MJ
Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
[TBL] [Abstract][Full Text] [Related]
19. Serum chemokine profile in patients with bullous pemphigoid.
Nakashima H; Fujimoto M; Asashima N; Watanabe R; Kuwano Y; Yazawa N; Maruyama N; Okochi H; Kumanogoh A; Tamaki K
Br J Dermatol; 2007 Mar; 156(3):454-9. PubMed ID: 17300233
[TBL] [Abstract][Full Text] [Related]
20. Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis.
Furuse S; Fujii H; Kaburagi Y; Fujimoto M; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2003 Jul; 30(7):1524-8. PubMed ID: 12858452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
